2023 international evidence-based guideline pcos glp-1 receptor agonist Getting a grip on polycystic ovary syndrome Ozempic (Semaglutide) for PMOS/PCOS: Pelvic

[DOI] [PubMed] [Google Scholar] 47.Locatelli J.C., Costa J.G., Haynes A., Naylor L.H., Fegan P.G., Yeap B.B., Green D.J

1 You read that right: It wasnt originally designed as a weight loss drug at all

Analysis of FAERS data from 2004 to 2020 revealed significant associations between GLP-1 RA and various neoplasms, notably medullary thyroid cancer (PRR, 27.43), papillary thyroid cancer (PRR, 8.68), malignant pancreatic neoplasms (PRR, 9.86), and pancreatic neuroendocrine neoplasms (PRR, 2.86) [52]

2021;12 doi: 10.3389/fendo.2021.689678

The CV benefits extend to the promising effects in improving HF outcomes

This is very different from natural GLP-1 hormones, which rise and fall in complex patterns finely tuned to your food intake and other behaviors